Kerget, B. Et Al. 2022. When and how important is anti-fibrotic therapy in the post-COVID-19 period?. Bratislavske lekarske listy , vol.123, no.9 , 653-6958.

Kerget, B., Cil, G., Araz, O., Alper, F., & Akgun, M., (2022). When and how important is anti-fibrotic therapy in the post-COVID-19 period?. Bratislavske lekarske listy , vol.123, no.9, 653-6958.

Kerget, Buğra Et Al. "When and how important is anti-fibrotic therapy in the post-COVID-19 period?," Bratislavske lekarske listy , vol.123, no.9, 653-6958, 2022

Kerget, Buğra Et Al. "When and how important is anti-fibrotic therapy in the post-COVID-19 period?." Bratislavske lekarske listy , vol.123, no.9, pp.653-6958, 2022

Kerget, B. Et Al. (2022) . "When and how important is anti-fibrotic therapy in the post-COVID-19 period?." Bratislavske lekarske listy , vol.123, no.9, pp.653-6958.

@article{article, author={Buğra KERGET Et Al. }, title={When and how important is anti-fibrotic therapy in the post-COVID-19 period?}, journal={Bratislavske lekarske listy}, year=2022, pages={653-6958} }